Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK-369,003 Modified Release in pulmonary hypertension associated with COPD
2004-002216-28Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Pulmonary hypertension associated with chronic obstructive pulmonary disease (COPD-PH) comparing UK-369,003MR with Placebo (2 arms). Primary endpoint: Change from baseline in total distance walked during a 6-minute walk test at week 12. Started Feb 2005; status: completed.
02
Drugs
UK-369,003MR
03
Conditions
Pulmonary hypertension associated with chronic obstructive pulmonary disease (COPD-PH)
Beyond the preview
Go deeper on 2004-002216-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002216-28.